Prevalence of intestinal parasitic infections in patients with diabetes: a systematic review and meta-analysis.


Journal

International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095

Informations de publication

Date de publication:
02 Jan 2024
Historique:
received: 25 10 2022
revised: 03 03 2023
accepted: 23 03 2023
medline: 3 1 2024
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

Patients with diabetes are at an increased risk of intestinal parasitic infections (IPIs). We evaluated the pooled prevalence and OR of IPIs in patients with diabetes through a systematic review and meta-analysis. A systematic search was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol for studies reporting IPIs in patients with diabetes through 1 August 2022. The collected data were analyzed using comprehensive meta-analysis software version 2. Thirteen case-control studies and nine cross-sectional studies were included in this study. The overall prevalence of IPIs in patients with diabetes was calculated to be 24.4% (95% CI 18.8 to 31%). Considering the case-control design, the prevalence of IPIs in case (25.7%; 95% CI 18.4 to 34.5%) was higher than controls (15.5%; 95% CI 8.4 to 26.9%) and a significant correlation was observed (OR, 1.80; 95% CI 1.08 to 2.97%). Moreover, a significant correlation was seen in the prevalence of Cryptosporidium spp. (OR, 3.30%; 95% CI 1.86 to 5.86%), Blastocystis sp. (OR, 1.57%; 95% CI 1.11 to 2.22%) and hookworm (OR, 6.09%; 95% CI 1.11 to 33.41%) in the cases group. The present results revealed a higher prevalence of IPIs in patients with diabetes than in controls. Therefore, the results of this study suggest a proper health education program to preventing measures for the acquisition of IPIs in patients with diabetes.

Identifiants

pubmed: 37052134
pii: 7116935
doi: 10.1093/inthealth/ihad027
pmc: PMC10759288
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-34

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Références

Microb Pathog. 2022 Aug;169:105639
pubmed: 35716924
Trans R Soc Trop Med Hyg. 2019 May 1;113(5):234-241
pubmed: 30624729
Nat Rev Immunol. 2003 Sep;3(9):733-44
pubmed: 12949497
Diabetes Care. 2011 Jun;34(6):1249-57
pubmed: 21617109
Parasitol Today. 1993 Jul;9(7):258-60
pubmed: 15463773
Infection. 2008 Jun;36(3):226-30
pubmed: 18454342
Int J Parasitol. 2013 Mar;43(3-4):259-74
pubmed: 23298637
BMC Public Health. 2020 Jan 28;20(1):117
pubmed: 31992252
Parasite Immunol. 2017 May;39(5):
pubmed: 27716947
Arch Med Res. 2019 Jan;50(1):58-59
pubmed: 30879759
Mult Scler. 2011 Jun;17(6):743-54
pubmed: 21372112
Acta Trop. 2019 Jul;195:58-61
pubmed: 31022382
Parasite Immunol. 2015 Jun;37(6):304-13
pubmed: 25869527
PLoS Negl Trop Dis. 2023 Feb 24;17(2):e0011022
pubmed: 36827239
Microb Pathog. 2022 Jan;162:105215
pubmed: 34592369
Rev Inst Med Trop Sao Paulo. 2021 Apr 23;63:e32
pubmed: 33909846
Microb Pathog. 2021 Oct;159:105083
pubmed: 34246749
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1027-1042
pubmed: 31873864
Metab Brain Dis. 2020 Jan;35(1):95-110
pubmed: 31352539
Pathog Glob Health. 2021 Feb;115(1):7-20
pubmed: 33433291
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2335-2342
pubmed: 28741097
Int J Environ Res Public Health. 2020 Nov 29;17(23):
pubmed: 33260351
J Parasit Dis. 2021 Dec;45(4):1106-1113
pubmed: 34789996
Clin Rev Allergy Immunol. 2012 Feb;42(1):5-15
pubmed: 22090147
PLoS One. 2020 Apr 23;15(4):e0232143
pubmed: 32324817
Parasite Immunol. 2015 Jun;37(6):277-92
pubmed: 25600983
Parasitol Res. 2019 Apr;118(4):1087-1094
pubmed: 30758662
J Parasitol Res. 2020 Nov 20;2020:8855965
pubmed: 33294218
BMC Res Notes. 2018 Oct 1;11(1):689
pubmed: 30285833
Inflamm Bowel Dis. 2019 Oct 18;25(11):e137
pubmed: 31300821
Lancet. 2006 May 6;367(9521):1521-32
pubmed: 16679166
BMC Infect Dis. 2021 Jan 7;21(1):20
pubmed: 33413119
BMC Res Notes. 2015 Feb 25;8:55
pubmed: 25888883
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Inflamm Bowel Dis. 2009 Jan;15(1):128-33
pubmed: 18680198
Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):738-741
pubmed: 28362138
PLoS One. 2022 May 31;17(5):e0269080
pubmed: 35639713
Trans R Soc Trop Med Hyg. 2021 May 8;115(5):457-470
pubmed: 33007067
PLoS One. 2014 Nov 03;9(11):e111868
pubmed: 25365580
Mucosal Immunol. 2009 Nov;2(6):527-35
pubmed: 19741601
J Diabetes Res. 2018 Feb 6;2018:4238435
pubmed: 29541642
Diabetes Care. 2012 Mar;35(3):520-5
pubmed: 22279028
Parasitol Res. 2017 Sep;116(9):2361-2371
pubmed: 28668983
J Infect Dis. 2002 Feb 15;185 Suppl 1:S96-101
pubmed: 11865446
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Epidemiol Infect. 2018 Nov;146(15):1880-1890
pubmed: 29991366
Nat Immunol. 2001 Sep;2(9):759-61
pubmed: 11526377
Pediatr Diabetes. 2016 Jul;17 Suppl 22:31-6
pubmed: 27411434
Trends Parasitol. 2003 Nov;19(11):477-8
pubmed: 14580957
Lancet. 2006 May 13;367(9522):1556-8
pubmed: 16698395
Diabetes Res Clin Pract. 2016 Oct;120:209-20
pubmed: 27596058
Diabetes Care. 2018 Dec;41(12):2502-2508
pubmed: 30373735
Int J Environ Health Res. 2022 Apr;32(4):808-818
pubmed: 32729738
Parasite Immunol. 2006 Oct;28(10):515-23
pubmed: 16965287
Am J Med Genet. 2002 May 30;115(1):18-29
pubmed: 12116173
Front Immunol. 2014 Feb 12;5:53
pubmed: 24575099
Parasitol Res. 2010 Jul;107(2):295-307
pubmed: 20407910
Exp Gerontol. 2020 May;133:110852
pubmed: 32007545
Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S134-S139
pubmed: 30774820
PLoS One. 2019 Oct 15;14(10):e0223722
pubmed: 31613921
Diabetes Care. 2001 Aug;24(8):1503-4
pubmed: 11473099
Rev Diabet Stud. 2007 Spring;4(1):13-24
pubmed: 17565412
PLoS One. 2016 Jan 25;11(1):e0147601
pubmed: 26808317
Nature. 2010 Apr 29;464(7293):1293-300
pubmed: 20432533
Trends Parasitol. 2002 Jun;18(6):272-8
pubmed: 12036742
J Cell Physiol. 2019 Jun;234(6):8550-8569
pubmed: 30480810

Auteurs

Ali Taghipour (A)

Zoonoses Research Center, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.

Ehsan Javanmard (E)

Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran 1417613151, Iran.

Hanieh Mohammad Rahimi (HM)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 4739-19395, Iran.

Amir Abdoli (A)

Zoonos es Research Center, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.
Department of Medical Parasitology and Mycology, School of Medicine, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.

Sara Matin (S)

Department of Pediatrics, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.

Marzieh Haghbin (M)

Clinical Research Development Unit of Peymanieh Hospital, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom 3713649373, Iran.

Meysam Olfatifar (M)

Gastroenterology and Hepataology Diseases Research Center, Qom University of Medical Sciences, Qom 4739-19395, Iran.

Hamed Mirjalali (H)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 4739-19395, Iran.

Mohammad Reza Zali (MR)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 4739-19395, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH